These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8698440)
41. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Komai N; Ohishi M; Morishita R; Moriguchi A; Kaibe M; Matsumoto K; Rakugi H; Higaki J; Ogihara T Am J Hypertens; 2002 Jun; 15(6):499-506. PubMed ID: 12074350 [TBL] [Abstract][Full Text] [Related]
42. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259 [TBL] [Abstract][Full Text] [Related]
43. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763 [TBL] [Abstract][Full Text] [Related]
44. Effects of cilazapril on the retinal vessels in spontaneously hypertensive rats: corrosion cast and scanning electron microscopic study. Bhutto IA; Amemiya T Life Sci; 1999; 64(3):PL27-39. PubMed ID: 10027753 [TBL] [Abstract][Full Text] [Related]
45. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380 [TBL] [Abstract][Full Text] [Related]
46. [Cilazapril in the treatment of patients with arterial hypertension]. Talipova IZh; Zaslavskaia RM; Berkinbaev SF Klin Med (Mosk); 2002; 80(8):50-2. PubMed ID: 12360621 [TBL] [Abstract][Full Text] [Related]
47. Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol. Erb KA; Essig J; Breithaupt K; Belz GG Drugs; 1991; 41 Suppl 1():11-7. PubMed ID: 1712266 [TBL] [Abstract][Full Text] [Related]
49. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481 [TBL] [Abstract][Full Text] [Related]
50. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Clozel M; Kuhn H; Hefti F; Baumgartner HR Hypertension; 1991 Aug; 18(2):132-41. PubMed ID: 1653185 [TBL] [Abstract][Full Text] [Related]
51. Functional versus structural changes of forearm vascular resistance in hypertension. Schulte KL; Braun J; Meyer-Sabellek W; Wegscheider K; Gotzen R; Distler A Hypertension; 1988 Apr; 11(4):320-5. PubMed ID: 3356454 [TBL] [Abstract][Full Text] [Related]
52. Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats. Clozel JP; Hefti F J Cardiovasc Pharmacol; 1987 Sep; 10(3):350-5. PubMed ID: 2444785 [TBL] [Abstract][Full Text] [Related]
53. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension]. Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470 [TBL] [Abstract][Full Text] [Related]